Apžvalga
Akcijų kainos pasikeitimas
24 val.
Dabar
Min
16.71
Max
17.26
Rekomendacijos | Stiprus pirkimas |
|---|---|
12 mėnesių prognozė | +74.66% upside |
Kitas uždarbis | 2026-11-05 |
|---|
Naujienos nuotaikos
By Acuity
100%
0%
320 / 339 reitingas Healthcare
Crescent Biopharma Inc Grafikas
Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.
Susijusios naujienos
2026-09-20 04:01; UTC
Ethereum is declining, reversing four sessions of gains, with a cumulative return of -2.04% since Saturday amid ongoing geopolitical instability affecting markets.
Skaityti
2026-09-20 04:01; UTC
Ethereum is declining, reversing four sessions of gains, amid ongoing geopolitical instability related to the Middle East conflict affecting energy prices and markets.
Skaityti
2026-09-20 02:51; UTC
Bitcoin is modestly lower, continuing a trend since Saturday, as the People's Bank of China maintains its one-year Loan Prime Rate at 3.00%.
Skaityti
2026-09-20 02:51; UTC
Bitcoin is modestly lower, continuing a trend since Saturday's close, as the People's Bank of China maintains its one-year Loan Prime Rate at 3.00%.
Skaityti
2026-09-19 00:06; UTC
Hf Foods Group Inc. has terminated its $100 million equity offering program, with the stock declining in after-market trading following this decision.
Skaityti
2026-09-19 00:02; UTC
Block Inc is facilitating Ideal Nutrition's expansion to at least 20 U.S. locations, contributing to a modest increase in its stock during after-market hours.
Skaityti
2026-09-19 00:02; UTC
MongoDB reported after-market earnings of $771.77 million and EPS of $1.90, exceeding estimates, with stock trading higher in line with market trends.
Skaityti
2026-09-19 00:02; UTC
Accenture PLC and Anthropic announced a partnership to invest $1 billion each in AI safety, driving a significant increase in Accenture's stock price in after-hours trading.
Skaityti
2026-09-19 00:02; UTC
Shares lower in after-market as DOJ reviews antitrust lawsuit.
Skaityti
2026-09-19 00:02; UTC
Corning Inc's stock is modestly lower in after-market trading, potentially influenced by ASML Holding, despite four consecutive higher daily closes leading into this session.
Skaityti
2026-09-19 00:02; UTC
Kimberly-Clark Corp is higher in after-market trading following plans to divest assets related to its $40 billion Kenvue acquisition to address EU antitrust concerns.
Skaityti
2026-09-19 00:01; UTC
S&P Global Inc is experiencing modest gains in after-market trading, recovering from an early dip while remaining below its 20-day moving average.
Skaityti
2026-09-19 00:01; UTC
RTX Corp is seeing a modest decline in after-market trading, continuing a downward trend since Friday's close and remaining below its 20-day moving average.
Skaityti
2026-09-19 00:01; UTC
Union Pacific Corp shares are trading lower in after-market hours, despite UBS upgrading its rating to Buy and raising the price target to $339.
Skaityti
2026-09-18 23:41; UTC
Iovance Biotherapeutics granted inducement stock options for 179.75k shares to new employees, contributing to a modest decline in after-market hours.
Skaityti
2026-09-18 23:31; UTC
BlackRock Inc. shares are modestly lower in after-market trading amid heightened legal concerns as the DOJ considers intervention in an antitrust lawsuit against the company.
Skaityti
2026-09-18 23:26; UTC
State Street Corp declines in after-market trading as the U.S. Department of Justice considers intervention in a state antitrust lawsuit regarding energy price inflation.
Skaityti
2026-09-18 23:16; UTC
Union Pacific Corp's stock is trading higher in after-market hours following UBS's upgrade to Buy and a price target increase to $339, citing expected cargo growth.
Skaityti
2026-09-18 23:11; UTC
AutoNation Inc has been downgraded from Buy to Hold amid industry challenges, yet the stock is rising in after-market trading as the broader market advances.
Skaityti
2026-09-18 23:11; UTC
Leidos Holdings Inc. has secured an $85 million contract from the U.S. Department of War for aerospace systems design, with shares rising in after-market trading.
Skaityti
2026-09-18 23:06; UTC
AbbVie Inc. is experiencing a slight decline in after-market trading, positioned near the lower end of its recent trading range despite promising myeloma study results.
Skaityti
2026-09-18 23:06; UTC
Boeing is in talks with NASA to expand its Starliner program, potentially adding ten or more flights, as the stock moves higher in after-hours trading.
Skaityti
2026-09-18 23:06; UTC
Chevron Corp has declined in after-market trading, despite Goldman Sachs raising its price target to $240 and Piper Sandler setting an even higher target of $243.
Skaityti
2026-09-18 23:06; UTC
Okta Inc appointed Helen Riley to its board, enhancing leadership as shares rise in after-market trading, aligning with a broader market advance.
Skaityti
2026-09-18 23:06; UTC
Nike shares are advancing in after-market hours despite recent challenges, including a significant decline and hitting a 12-year low.
Skaityti
2026-09-18 23:06; UTC
General Motors Co is advancing in after-market trading following its decision to reinstate Apple’s CarPlay and Android Auto in its vehicles.
Skaityti
2026-09-18 23:06; UTC
Medtronic PLC raised its fiscal 2027 profit forecast and reported first-quarter revenue of $9.756 billion, exceeding expectations, in after-market trading.
Skaityti
2026-09-18 23:06; UTC
RTX Corp's backlog hit a record $289 billion, with the stock advancing in after-market trading, despite remaining below its 20-day moving average.
Skaityti
2026-09-18 23:06; UTC
Celsius Holdings Inc shares are higher in after-market trading, continuing a positive trend despite ongoing legal scrutiny over its Alani Nu product line.
Skaityti
2026-09-18 23:01; UTC
Northrop Grumman targets $10 billion in annual international sales by 2031, while shares trade lower in after-market hours.
Skaityti
Akcijų palyginimas
Kainos pokytis
Crescent Biopharma Inc Prognozė
Kainos tikslas
By TipRanks
12 mėnesių prognozė
Vidutinis 29.5 USD 74.66%
Aukščiausias 35 USD
Žemiausias 27 USD
Remiantis 5 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Crescent Biopharma Inc kainas – Dist per pastaruosius 3 mėnesius.
Bendras įvertinimas
By TipRanks
Stiprus pirkimas
5 ratings
4
Pirkti
1
Laikyti
0
Parduoti
Remiantis 5 analitikų, pateikusių Crescent Biopharma Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.
Rinkos nuotaikos
By Acuity
Naujienos nuotaikos
Labai stiprus meškų rinkos įrodymas
Svyravimai
Žemiau vidurkio
Naujienų apimtis (RCV)
Žemiau vidurkio
Finansinės naujienos
$